Industry Trends
Home > News > Industry Trends >Market Trends: From Extensive Supplementation to Precision Intervention

The global probiotic market was undergoing a structural transformation from "extensive supplementation" to "targeted precision intervention," with continuing expansion in market scale and research investment.
Market Size and Growth
The global probiotic market was valued around US$76.6 billion in 2025 and expected to reach US$115 billion by 2030, growing around 8.5% annually. Asia-Pacific was the largest market, holding about 45.9% share in 2024. Dietary supplements were the largest product category at 38% market value in 2026, while digestive health was the leading application area at 42%.
New Trends in Gut Health and Weight Management
In 2026 China Gut Health and Innovation Conference, experts identified targeted microbiome regulation as new trend in weight management. The gut microbiota and brain communication through gut-brain axis, and metabolites such as short-chain fatty acids and bile acids could regulate energy intake and expenditure. Professor Liu Shuangjiang presented research on the patented strain Lactobacillus reuteri GOLDGUT-LR99 and the animal studies showed it might relieve anxiety-behaviour, improving rapid intestinal transit and reduce visceral hypersensitivity.
Industrial Transformation of Next-Generation Probiotics
International researchers were moving probiotics from general dietary supplements toward next-generation precision live biotherapeutic products with clear mechanisms and clinical potential. These included natural human commensal strains, engineered strains and synthetic multi-kingdom microbiota. However, commercialisation still faced challenges such as insufficient strain characterisation, poor host specificity and differing regulatory frameworks.
Accelerating Industry Standardisation
China’s first revision of probiotic health food registration and filing rules, together with global consensus on strain-level control, showed the industry shifting from “concept hype” to “evidence-based verification.” Companies should study product lines, strengthen strain-specific scientific evidence and avoid vague claims for stricter regulations and consumer expectations.